BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

METiS TechBio’s AI-Designed MTS-004 Meets Phase III Success in China, Targeting Pseudobulbar Affect

MTS-004 Poised to Fill an Unmet Need in the Treatment of Pseudobulbar Affect (PBA) METiS TechBio, a global leader in AI-driven nanodelivery and formulatio...

October 24, 2025 | News

Teijin Pharma Licenses Rheumatoid Arthritis Drug Candidate TCK-276 to UK-Based Elevara Medicines in Global Agreement

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that has entered into an exclusive ...

October 24, 2025 | News

HMI Medical and Siemens Healthineers Strengthen Strategic Partnership with Launch of HMI Radiology (Novena) in Singapore

HMI Radiology (Novena) will deliver a full suite of diagnostic imaging services to aid in early detection and proactive health management in the communit...

October 23, 2025 | News

GE HealthCare Secures CE Mark for Carevance™ Patient Monitor, Advancing Accessible and Reliable Acute Care Across Europe

Built on GE HealthCare’s 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitoring solution that leve...

October 23, 2025 | News

AdvanCell’s Lead-212 Radioligand Therapy Shows Strong Safety and Efficacy in Phase 1b Trial for Metastatic Prostate Cancer

Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with metastat...

October 22, 2025 | News

Olympus Launches THUNDERBEAT™ II, a Next-Generation Hybrid Energy Device for Precision and Versatility in Surgery

THUNDERBEAT™ II features the versatility of three energy modes to support surgeons in adapting to challenging clinical conditions Olympus Corporatio...

October 22, 2025 | News

Ascletis Completes U.S. Phase IIa Enrollment for Once-Monthly ASC30 GLP-1 Depot Therapy in Obesity

The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) d...

October 20, 2025 | News

NUH and NUS Launch Singapore’s First Total-Body PET/CT Centre in Partnership with Siemens Healthineers

Powered by Singapore's first next-generation total-body PET/CT system, the new facility aims to transform diagnostics, treatment and research i...

October 17, 2025 | News

SK Bioscience Files Clinical Trial Application in Australia for GBP511 Universal Coronavirus Vaccine

Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results e...

October 16, 2025 | News

Ascletis’ Denifanstat (ASC40) Achieves Phase III Success in Moderate-to-Severe Acne Vulgaris

Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulga...

October 15, 2025 | News

Lundbeck’s Bexicaserin Receives Breakthrough Therapy Designation in China for Severe Childhood Epilepsies

Accelerated pathway underscores urgent need for innovative solutions for patients with devastating, childhood-onset epilepsies Novel 5HT2C mechanism des...

October 14, 2025 | News

Anthony Elgamal: Redefining First-Line Treatment in EGFR-Mutated Lung Cancer

BioPharma APAC speaks with Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific, on th...

October 13, 2025 | Expert Insight

Jenscare’s LuX-Valve Plus Approved for Use in Greater Bay Area Under Hong Kong-Macao Medicine and Equipment Connect

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with comprehensive structural heart disease ...

October 13, 2025 | News

IHH Healthcare Launches Global Incubator Programme to Empower Early-Stage Startups

By enabling early-stage start-ups to bring breakthrough ideas to life, IHH is catalysing next-level care and driving lasting impact across the healthc...

October 13, 2025 | News

Stay Connected